Recent Activity

Loading...

GSK

GSK plc Sponsored ADR · NYSE

Performance

+6.1%

1W

+7.19%

1M

+6.75%

3M

+29.4%

6M

+20.26%

YTD

+24.85%

1Y

Profile

GSK plc, together with its subsidiaries, engages in the research, development and manufacture of vaccines and specialty medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as infectious disease, HIV, immunology and respiratory, and oncology. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is based in Brentford, the United Kingdom.

Investment Analysis Report: GSK

Overview

In this investment analysis report, we will delve into a comprehensive analysis of GlaxoSmithKline (GSK) based on the provided financial information. We will focus on evaluating the company's valuation, financial health, earnings and revenue growth, profitability, operating margin, operating cash flow ana...

See more ...

Technical Analysis of GSK 2024-05-03

Overview:

In analyzing the technical indicators for GSK over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key factors, we aim to offer valuable insights and predictions for the upcoming days.

Trend Analysis:

    ...
See more ...

Recent News & Updates